King’s College backs probiotic at gastroenterology conference

By Shane Starling

- Last updated on GMT

King’s College backs probiotic

Related tags Irritable bowel syndrome Gastroenterology

Research backing the gastrointestinal potential of a multi-strain probiotic-fibre product is being presented at United European Gastroenterology Congress in Amsterdam today – a rare speaking opportunity at a medical-focused event with 12,000 attendees.

The as yet unpublished King’s College (London) research found a significant reduction in irritable bowel syndrome (IBS) among 186 patients with moderate to severe forms of the ailment when they consumed Symprove.

King’s College is running a second trial with Symprove focused on Inflammatory Bowel Disease (IBD). A Symprove spokesperson said the company had no plans to submit a health claim application the European Union until the IBD study concluded, which was not for another two months.

It is estimated IBS affects more than 10 million people in the UK, with women more than twice as likely to suffer from it than men. Typical symptoms include stomach cramps and pain, diarrhoea, constipation and bloating.

One of the researchers, professor Guy Sisson, from the Department of Gastroenterology at King’s College Hospital, will tell the ‘New pharmacological treatment options for lower GI diseases’ congress that blends like Symprove represented next generation” ​products due to, “its preparation.”

Furthermore, there is now scientific data to show the efficacy of Symprove to improve the overall symptoms of IBS.”

Symprove contains Lactobacillus rhamnosus, acidophilus and plantarum​ and Enterococcus faecium​.

Pickled grain

Symprove developed out of work using germinated grain which was fed to livestock as an alternative to other feeds that typically contained artificial supplements and hormones.

Pickling the germinated grain with lactic acids extended its shelf life and it was then noted that a beneficial side effect was the growth of probiotic strains drawn from the Lactobacillus genus.

Animals on this diet also exhibited greater lean weight gain and less digestive problems.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Custom Biotic Solutions for Digestive Health

Custom Biotic Solutions for Digestive Health

Content provided by ADM: Innovation that Feeds the Future | 10-Oct-2023 | White Paper

A growing body of evidence shows gut health can affect digestive health, well-being, and many health areas in between.

Related suppliers

1 comment

Good Research

Posted by jose Valdai de Souza,

I´m used lactobaciluas rhamnosus and othes together about 20 years, From Russia and others Contry here in BRasil. Many diseasis, gasteroenterology more frequent and result are very good. Low Omeprazol ou no im very large number of patients.

Report abuse

Follow us


View more